Recent reports of the Congressional Research Service on topics related to openness and transparency include the following (all pdf).
“Does Price Transparency Improve Market Efficiency? Implications of Empirical Evidence in Other Markets for the Health Sector,” July 24, 2007.
“State E-Government Strategies: Identifying Best Practices and Applications,” July 23, 2007.
“Clinical Trials Reporting and Publication,” updated July 12, 2007.
“Freedom of Information Act Amendments: 110th Congress,” updated July 10, 2007.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.
By leveraging its substantial purchasing power responsibly, the government can encourage high-quality, inclusive AI solutions that address diverse citizen needs while setting a strong precedent for innovation and accountability.